84 related articles for article (PubMed ID: 11396195)
1. Usefulness of galactose oxidase-Schiff test in rectal mucus for screening of colorectal malignancy.
Vucenik I; Gotovac J; Druzijanic N; Shamsuddin AM
Anticancer Res; 2001; 21(2B):1247-55. PubMed ID: 11396195
[TBL] [Abstract][Full Text] [Related]
2. Detection of the tumor marker D-galactose-beta-(1-->3)-N-acetyl-D-galactosamine in colonic cancer and precancer.
Xu H; Sakamoto K; Shamsuddin AM
Arch Pathol Lab Med; 1992 Nov; 116(11):1234-8. PubMed ID: 1332646
[TBL] [Abstract][Full Text] [Related]
3. Common expression of the tumor marker D-galactose-beta-[1-->3]-N-acetyl-D-galactosamine by different adenocarcinomas: evidence of field effect phenomenon.
Shamsuddin AM; Tyner GT; Yang GY
Cancer Res; 1995 Jan; 55(1):149-52. PubMed ID: 7805025
[TBL] [Abstract][Full Text] [Related]
4. Gal-GalNAc: a biomarker of colon carcinogenesis.
Yang GY; Shamsuddin AM
Histol Histopathol; 1996 Jul; 11(3):801-6. PubMed ID: 8839767
[TBL] [Abstract][Full Text] [Related]
5. [A new screening method for colorectal cancer as a replacement for the hemoccult blood test].
Sakamoto K; Nagamachi Y; Sugawara I
Gan No Rinsho; 1990 Jul; 36(8):865-70. PubMed ID: 2366322
[TBL] [Abstract][Full Text] [Related]
6. A simple mucus test for cancer screening.
Shamsuddin AM
Anticancer Res; 1996; 16(4B):2193-9. PubMed ID: 8694542
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a test for abnormal rectal mucus for early detection of colon cancer.
Kristal AR; Baker MS; Feld AD; Ylvisaker JT; Morse KA
Cancer Epidemiol Biomarkers Prev; 1992; 1(4):303-6. PubMed ID: 1303131
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects.
Zhou DY; Feng FC; Zhang YL; Lai ZS; Zhang WD; Li LB; Xu GL; Wan TM; Pan DS; Zhou D
Chin Med J (Engl); 1993 Oct; 106(10):739-42. PubMed ID: 8033605
[TBL] [Abstract][Full Text] [Related]
9. Validation of the galactose oxidase-Schiff's reagent sequence for early detection and prognosis in human colorectal adenocarcinoma.
Carter JH; Deddens JA; Pullman JL; Colligan BM; Whiteley LO; Carter HW
Clin Cancer Res; 1997 Sep; 3(9):1479-89. PubMed ID: 9815834
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of galactose oxidase-Schiff reaction in the detection of carcinoma and precancerous lesions of large intestine].
Qin J; Zhang Q; Fang X
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):157-9. PubMed ID: 10743086
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different techniques for detection of Gal-GalNAc, an early marker of colonic neoplasia.
Said IT; Shamsuddin AM; Sherief MA; Taleb SG; Aref WF; Kumar D
Histol Histopathol; 1999 Apr; 14(2):351-7. PubMed ID: 10212796
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer detection by measuring DNA from exfoliated colonocytes obtained by direct contact with rectal mucosa.
Loktionov A; Bandaletova T; Llewelyn AH; Dion C; Lywood HG; Lywood RC; Rockall TA; Stebbing JF; Broughton M; Caffarey S; Marks CG
Int J Oncol; 2009 Feb; 34(2):301-11. PubMed ID: 19148463
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of colorectal endoscopic mucosal resection using high-magnification chromoscopic colonoscopy: a prospective study of 1000 colonoscopies.
Hurlstone DP; Cross SS; Drew K; Adam I; Shorthouse AJ; Brown S; Sanders DS; Lobo AJ
Endoscopy; 2004 Jun; 36(6):491-8. PubMed ID: 15202044
[TBL] [Abstract][Full Text] [Related]
14. Expression of the tumor marker D-galactose-beta-[1-->3]-N-acetyl-D-galactosamine by premalignant and malignant prostate.
Shamsuddin AM; Beasley WM
Arch Pathol Lab Med; 1994 Jan; 118(1):48-51. PubMed ID: 7506904
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of different stool tests for the detection of cancer of the colon].
Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new test for colorectal neoplasms: a prospective study of asymptomatic population.
Sakamoto K; Muratani M; Ogawa T; Nagamachi Y
Cancer Biother; 1993; 8(1):49-55. PubMed ID: 7812349
[TBL] [Abstract][Full Text] [Related]
17. Immunodiagnostic potential of mucin (MUC2) and Thomsen-Friedenreich (TF) antigens in Egyptian patients with colorectal cancer.
El-Sayed IH; Lotfy M; Moawad M
Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):91-7. PubMed ID: 21381504
[TBL] [Abstract][Full Text] [Related]
18. Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test.
Ruffin MT; Normolle DP; Evelegh MJ; Baron JA; Bresalier RS; Marcon NE; Syngal S; Turgeon DK; Tuck MK; Brenner DE
Cancer Biomark; 2010-2011; 8(2):109-12. PubMed ID: 21896998
[TBL] [Abstract][Full Text] [Related]
19. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
20. Variation in cyclooxygenase expression levels within the colorectum.
Wiese FW; Thompson PA; Warneke J; Einspahr J; Alberts DS; Kadlubar FF
Mol Carcinog; 2003 May; 37(1):25-31. PubMed ID: 12720297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
